Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Major change: update to v3.2.0 with a prominent notice about government funding status and operating status; removal of v3.1.0. If any time-sensitive content is shown elsewhere, it may now reflect the new version and funding status.
    Difference
    1%
    Check dated 2025-10-04T04:10:21.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0 with no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-27T02:17:03.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Removed the 'Back to Top' link; no significant content changes were made.
    Difference
    0.1%
    Check dated 2025-09-19T23:20:54.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-11T16:44:02.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content. The 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-04T13:50:36.000Z thumbnail image
  9. Check
    59 days ago
    Change Detected
    Summary
    The webpage has added significant information regarding facility names, locations, and drug information for Lebrikizumab, while also removing several location entries and terms. This indicates a refinement in the content related to clinical trials and their geographical context.
    Difference
    28%
    Check dated 2025-08-28T10:10:55.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.